GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is now emerging as a significant focus in medical studies, largely due to its impressive impact on treating ailments such as adult-onset diabetes and obesity. Ongoing trials have revealed that more than glucose control, GLP-1 drugs offer